Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

1,124 companies

Ticker	Company	Revenue	Net income	Net margin	Return on equity ▴	Revenue growth	Diluted EPS
CLAR	Clarus Corp Manufacturing · Year ended 2025-12-31 · USD	$250.44M	-$46.56M	-18.6%	-23.7%	-5.2%	-$1.21
WSTRF	Western Uranium & Vanadium Corp. Mining · Year ended 2025-12-31 · USD	$425.4K	-$7.18M	n/m	-23.7%	131.5%	-$0.11
MBX	MBX Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$86.97M	n/a	-23.6%	n/a	-$2.38
STAA	Staar Surgical Co Manufacturing · Year ended 2026-01-02 · USD	$239.44M	-$80.45M	-33.6%	-23.4%	-23.7%	-$1.62
TRVI	Trevi Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$42.76M	n/a	-23.3%	n/a	-$0.32
RIOT	Riot Platforms, Inc. Finance & Real Estate · Year ended 2025-12-31 · USD	$647.43M	-$663.18M	-102.4%	-23.2%	71.9%	-$1.95
OUST	Ouster, Inc. Manufacturing · Year ended 2025-12-31 · USD	$169.38M	-$60.38M	-35.6%	-23.1%	52.5%	-$1.07
DGXX	Digi Power X Inc. Finance & Real Estate · Year ended 2025-12-31 · USD	$34.19M	-$28.36M	-82.9%	-23.0%	-7.6%	-$0.64
RAPP	Rapport Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$111.48M	n/a	-23.0%	n/a	-$2.86
SOS	SOS Ltd Finance & Real Estate · Year ended 2025-12-31 · USD	$154.29M	-$97.32M	-63.1%	-23.0%	-33.3%	-$6.02
CTNM	Contineum Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$59.98M	n/a	-23.0%	n/a	-$2.17
USBC	USBC, Inc. Finance & Real Estate · Year ended 2025-09-30 · USD	n/a	-$22.12M	n/a	-22.8%	n/a	-$0.39
MGLD	Marygold Companies, Inc. Finance & Real Estate · Year ended 2026-06-30 · USD	$25.31M	-$4.37M	-17.3%	-22.7%	8.0%	-$0.10
ELVN	Enliven Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$103.69M	n/a	-22.6%	n/a	-$1.83
SLDP	Solid Power, Inc. Manufacturing · Year ended 2025-12-31 · USD	$21.75M	-$93.41M	-429.5%	-22.5%	8.0%	-$0.51
AMBQ	Ambiq Micro, Inc. Manufacturing · Year ended 2025-12-31 · USD	$72.51M	-$36.46M	-50.3%	-22.4%	-4.7%	-$4.57
ORKA	Oruka Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$105.43M	n/a	-22.3%	n/a	n/a
REEMF	Rare Element Resources Ltd Mining · Year ended 2025-12-31 · USD	$0	-$4.90M	n/a	-22.0%	n/a	-$0.01
IVVD	Invivyd, Inc. Manufacturing · Year ended 2025-12-31 · USD	$53.43M	-$52.49M	-98.2%	-21.7%	110.5%	-$0.30
SYRE	Spyre Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$155.20M	n/a	-21.7%	n/a	n/a
FULC	Fulcrum Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$74.88M	n/a	-21.5%	-100.0%	-$1.18
CGON	CG Oncology, Inc. Manufacturing · Year ended 2025-12-31 · USD	$4.04M	-$161.00M	n/m	-21.4%	254.7%	-$2.08
RDW	Redwire Corp Manufacturing · Year ended 2025-12-31 · USD	$335.38M	-$226.55M	-67.6%	-21.4%	10.3%	-$2.28
OSRH	OSR Health, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.91M	-$27.06M	-931.2%	-21.3%	-17.7%	-$0.80
PTGX	Protagonist Therapeutics, Inc Manufacturing · Year ended 2025-12-31 · USD	$46.02M	-$130.15M	-282.8%	-21.2%	-89.4%	-$2.05

Rows per page: 2550 100